MRNS Historical PE Ratio image   This MRNS PE ratio history page last updated 11/9/2022
MRNS Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/7/2022
5.61-0.94-3.76NA
Q2 2022
8/11/2022
5.77-1.06-4.24NA
Q1 2022
5/12/2022
4.86-0.52-2.08NA
Q4 2021
3/21/2022
8.74-0.77-3.08NA
Q3 2021
11/9/2021
12.68-0.53-2.12NA
Q2 2021
8/10/2021
13.12-0.65-2.60NA
Q1 2021
5/17/2021
15.03-0.74-2.96NA
Q4 2020
3/9/2021
18.62-0.55-2.20NA
Q3 2020
11/9/2020
13.71-0.51-2.04NA
Q2 2020
8/6/2020
8.36-0.64-2.56NA
Q1 2020
5/4/2020
7.20-1.28-5.12NA
Q4 2019
3/16/2020
4.76-1.00-4.00NA
Q3 2019
11/6/2019
4.60-1.04-4.16NA
Q2 2019
8/8/2019
4.64-0.96-3.84NA
Q1 2019
5/1/2019
16.60-0.96-3.84NA
Q4 2018
3/11/2019
15.76-0.96-3.84NA
Q3 2018
10/29/2018
19.48-1.08-4.32NA
Q2 2018
8/2/2018
24.46-0.96-3.84NA
Q1 2018
5/2/2018
18.96-0.60-2.40NA
Q4 2017
3/6/2018
18.12-0.72-2.88NA
Q3 2017
10/31/2017
22.16-0.60-2.40NA
Q2 2017
8/1/2017
7.32-0.84-3.36NA
Q1 2017
5/1/2017
5.52-1.04-4.16NA
Q4 2016
3/13/2017
6.80-1.24-4.96NA
Q3 2016
11/3/2016
4.20-1.32-5.28NA
Q2 2016
8/8/2016
5.92-1.84-7.36NA
Q1 2016
5/2/2016
21.68-1.48-5.92NA
Q4 2015
3/7/2016
23.80-1.80-7.20NA
Q3 2015
10/29/2015
31.24-1.40-5.60NA
Q2 2015
8/4/2015
77.52-1.48-5.92NA
Q1 2015
5/11/2015
31.60-2.00-8.00NA
Q4 2014
3/12/2015
41.642.489.924.2
Q3 2014
11/13/2014
25.44-0.88-3.52NA
MRNS PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/7/2022
5.61-0.94-3.29NA
Q2 2022
8/11/2022
5.77-1.06-2.88NA
Q1 2022
5/12/2022
4.86-0.52-2.47NA
Q4 2021
3/21/2022
8.74-0.77-2.69NA
Q3 2021
11/9/2021
12.68-0.53-2.47NA
Q2 2021
8/10/2021
13.12-0.65-2.45NA
Q1 2021
5/17/2021
15.03-0.74-2.44NA
Q4 2020
3/9/2021
18.62-0.55-2.98NA
Q3 2020
11/9/2020
13.71-0.51-3.43NA
Q2 2020
8/6/2020
8.36-0.64-3.96NA
Q1 2020
5/4/2020
7.20-1.28-4.28NA
Q4 2019
3/16/2020
4.76-1.00-3.96NA
Q3 2019
11/6/2019
4.60-1.04-3.92NA
Q2 2019
8/8/2019
4.64-0.96-3.96NA
Q1 2019
5/1/2019
16.60-0.96-3.96NA
Q4 2018
3/11/2019
15.76-0.96-3.60NA
Q3 2018
10/29/2018
19.48-1.08-3.36NA
Q2 2018
8/2/2018
24.46-0.96-2.88NA
Q1 2018
5/2/2018
18.96-0.60-2.76NA
Q4 2017
3/6/2018
18.12-0.72-3.20NA
Q3 2017
10/31/2017
22.16-0.60-3.72NA
Q2 2017
8/1/2017
7.32-0.84-4.44NA
Q1 2017
5/1/2017
5.52-1.04-5.44NA
Q4 2016
3/13/2017
6.80-1.24-5.88NA
Q3 2016
11/3/2016
4.20-1.32-6.44NA
Q2 2016
8/8/2016
5.92-1.84-6.52NA
Q1 2016
5/2/2016
21.68-1.48-6.16NA
Q4 2015
3/7/2016
23.80-1.80-6.68NA
Q3 2015
10/29/2015
31.24-1.40-2.40NA
Q2 2015
8/4/2015
77.52-1.48-1.88NA
Q1 2015
5/11/2015
31.60-2.00NANA
Q4 2014
3/12/2015
41.642.48NANA
Q3 2014
11/13/2014
25.44-0.88NANA
Quotes delayed 20 minutes

Email EnvelopeFree MRNS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Marinus Pharmaceuticals (MRNS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

MRSN PE Ratio History
MRTX PE Ratio History
MRVI PE Ratio History
MSON PE Ratio History
MTCR PE Ratio History
MTEM PE Ratio History
MXCT PE Ratio History
MYGN PE Ratio History
MYMD PE Ratio History
NAOV PE Ratio History
How should the MRNS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Marinus Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this MRNS Historical PE Ratio page.

What is the average historical PE for MRNS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The MRNS historical PE ratio using the annualized quarterly earnings method works out to 4.2.

What is the average historical PE for MRNS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The MRNS historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the MRNS Historical PE Ratio information for Marinus Pharmaceuticals' stock. The average MRNS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 4.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MRNS historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this MRNS historical PE result, against the recent PE: when this page was posted on 11/8/2022, the most recent closing price for MRNS had been 4.65, and the most recent quarterly earnings result, annualized, was 9.92. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent MRNS PE on 11/8/2022 based on annualized quarterly EPS was 0.5. Based on MRNS's history, that recent PE is low relative to the historical average, with the recent PE 88.1% lower than the historical average PE across our data set for Marinus Pharmaceuticals.

For self directed investors doing their due diligence on MRNS or any other given stock, valuation analysis for MRNS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Marinus Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MRNS. Thanks for visiting, and the next time you need to research MRNS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: JRSH Average Annual Return, SMTA Insider Buying, SBGI shares outstanding history.

 

MRNS Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.